English
This article is from International Journal of Preventive Medicine , volume 3 . Abstract Objectives:: Hepatitis C virus (HCV) is the major cause of post-transfusion hepatitis infection (PTH). Patients with thalassemia major are at high risk of hepatitis C due to the blood transfusion from donors infected by HCV. The aim of this study was to detect the prevalence of anti-HCV antibodies and risk factors in multitransfused thalassemic patients in Isfahan-Iran to establish more preventive strategies. Methods:: This study was conducted to assess the patients with beta-thalassemia in Isfahan hospitals during 1996-2011 for HCV infection. A structured interview questionnaire was developed by the trained researcher to collect the demographic and risk factors. Statistical analysis was done by Chi-square test, Mann-Withney and multiple logistic regressions using SPSS software, version 15. Results:: 466 patients with major thalassemia participated in this study. The mean age of patients was 17.46 ± 8.3. Two hundred and seventy (58.3%) and 193 (41.7%) of participants were male and female, respectively. The prevalence of HCV was estimated 8% among thalassemia patients. History of surgery, history
Sign in with your free account to read, download EPUBs or listen.
Ebook · Prevalence of Anti HCV Infection in Patients with Beta-Thalassemia in Isfahan-Iran. · Ataei, Behrooz, Hashemipour, Marjan, Kassaian, Nazila, Hassannejad, Razieh, Nokhodian, Zary, Adibi, Peyman · Internet Archive